The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 486-498

  Aston Jones, Gary ^a   Delfs, Jill M ^a   Druhan, Jonathan ^a   Zhu, Yan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; ICI 181 555; NORADRENALIN; OPIATE; PROPRANOLOL; TRACER; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; DRUG WITHDRAWAL; HUMAN; LOCUS CERULEUS; MEDULLA OBLONGATA; NERVE CELL; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; RAT; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS; SYMPTOM;

EID: 0032779967     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09284.x     Document Type: Conference Paper

References (44)

1. 1. Maldonado, R. 1997. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21: 91-104.
2. 2. Aston-Jones, G., R. Shiekhattar, J. Rajkowski, P, Kubiak & H. Akaoka. 1993. Opiates influence noradrenergic locus cocruleus neurons by potent indirect as well as direct effects. In The Neurobiology of Opiates. R. Hammer, Ed.: 175-202. CRC Press. New York.
3. 3. Moore, R.Y. 1978. Catecholamine innervation of the basal forebrain: I. The septal area. J. Comp. Neurol. 177: 665-684.
4. 4. Phelix, C.F., Z. Liposits & W.K. Paull. 1992. Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res. Bull. 28: 949-965.
5. 5. Alheid, G.F., J.S. De Olmos & C.A. Beltramino. 1995. Amygdala and extended amygdala. In The Rat Nervous System. G. Paxinos, Ed.: 495-578. Academic Press. New York.
6. 6. Alheid, G.F. & L. Heimer. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of the substantia inominata, Neuroscience 27: 1-39.
7. 7. Brog, J.S., A. Salyapongse, A.Y. Deutch & D.S. Zahm. 1993. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338: 255-278.
8. 8. Koob, G.F., P. Robeledo, A. Markou & S.B. Caine. 1993. The mesocorticolimbic circuit in drug dependence and reward - a role for the extended amygdala? In Limbic Motor Circuits and Neuropsychiatry. P. W. Kalivas & C.D. Barnes, Eds.: 289-309. CRC Press, Inc. Boca Raton, FL.
9. 9. Koob, G.F., F.J. Vaccarino, M. Amalric & F.E. Bloom. 1986. Neurochemical substrates for opiate reinforcement. NIDA Res. Monogr. 71: 146-164.
10. 10. Vaccarino, F.J., F.E. Bloom & G.F. Koob. 1985. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86: 37-42.
11. 11. Kelsey, J.E., W.A. Carlezon, Jr. & W.A. Falls. 1989. Lesions of the nucleus accumbens in rats reduce opiate reward but do not alter context-specific opiate tolerance. Behav. Neurosci. 103: 1327-1334.
12. 12. Harris, G. & G. Aston-Jones. 1994. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371: 155-157.
13. 13. Koob, G.F., T.L. Wall & F.E. Bloom. 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98: 530-534.
14. 14. Pothos, E., P. Rada, G.P. Mark & B.G. Hoebel. 1991. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566: 348-350.
15. 15. Rossetti, Z.L., Y. Hmaidan & G.L. Gessa. 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221: 227-234.
16. 16. Kelsey, J.E. & S.R. Arnold. 1994. Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats. Behav. Neurosci. 108: 1119-1127.
17. 17. De Olmos, J., G.F. Alheid & C.A. Beltramino. 1985. Amygdala. In The Rat Nervous System, Vol. 1: Forebrain and Midbrain. G. Paxinos, Ed.: 223-334. Academic Press. New York.
18. 18. Gray, T.S., R.A. Piechowski, J.M. Yracheta, P.A. Rittenhouse, C.L. Bethea & L.D. Van De Kar. 1993. Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 57: 517-24.
19. 19. Casada, J.H. & N. Dafny. 1992. Evidence for two different afferent pathways carrying stress-related information (noxious and amygdala stimulation) to the bed nucleus of the stria terminalis. Brain Res. 579: 93-98.
20. 20. Swanson, L.W. & P.E. Sawchenko. 1980. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410-417.
21. 21. Loewy, A.D. 1991. Forebrain nuclei involved in autonomic control. Prog. Brain Res. 87: 253-268.
22. 22. Terreberry, R.R., M. Oguri & R.M. Harper. 1995. State-dependent respiratory and cardiac relationships with neuronal discharge in the bed nucleus of the stria terminalis. Sleep 18: 139-144.
23. 23. Wilkinson, M.F. & Q.J. Pittman. 1995. Changes in arterial blood pressure alter activity of electrophysiologically identified single units of the bed nucleus of the stria terminalis. Neuroscience 64: 835-844.
24. 24. Ciriello, J. & S.A. Janssen. 1993. Effect of glutamate stimulation of bed nucleus of the stria terminalis on arterial pressure and heart rate. Am. J. Physiol. 265: H1516-1522.
25. 25. Roder, S. & J. Ciriello. 1993. Contribution of bed nucleus of the stria terminalis to the cardiovascular responses elicited by stimulation of the amygdala. J. Auton. Nerv. Syst. 45: 61-75.
26. 26. Swanson, L.W. & B.K. Hartman. 1975. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163: 467-505.
27. 27. Brownstein, M.J. & M. Palkovits. 1984. Catecholamines, scrotonin, acetylcholine, and gamma-aminobutyric acid in the rat brain: biochemical studies. In Handbook of Chemical Neuroanatomy, Vol. 2: Classical Transmitters in the CNS, Part 1. A. Björklund & T. Hokfelt, Eds.: 23-54. Elsevier Science Publishers B.V. Amsterdam.
28. 28. Ungerstedt, U. 1971. Stereotaxic mapping of monoamine pathways in the rat brain. Acta Physiol. Scand. Suppl. 367: 1-48.
29. 29. Harris, G. & G. Aston-Jones. 1993. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9: 303-311.
30. 30. Delfs, J.M., Y. Zhu, J.P. Druhan & G. Aston-Jones. 1998. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract tracing studies in the rat. Brain Res. 806: 127-140.
31. 31. Aston-Jones, G., M. Ennis, V.A. Pieribone, W.T. Nickell & M.T. Shipley. 1986. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science 234: 734-737.
32. 32. Akaoka, H., Y. Zhu, M.T. Shipley & G. Aston-Jones. 1992. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18.
33. 33. Stornetta, R.L., F.E. Norton & P.G. Guyenet. 1993. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624: 19-28.
34. 34. Britton, K., T. Svensson, J. Schwartz, F. Bloom & G. Koob. 1984. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34: 133-139.
35. 35. Chieng, B. & M.J. Christie. 1995. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci. Lett. 186: 37-40.
36. 36. Delfs, J.M., J.P. Druhan & G. Aston-Jones. 1997. Involvement of non-locus coeruleus (LC) projections to forebrain in the expression of opiate withdrawal-induced conditioned place aversion (CPA). Soc. Neurosci. Abstr. 23: 1108.
37. 37. Stinus, L., A. Peron, J.P. Reneric, M. Cador & G.F. Koob. 1997. In morphine dependent rats, the total lesion of locus coeruleus neurons docs not impair naloxone-induced withdrawal syndrome and conditioned place aversion, or the protective effects of clonidine upon opiate withdrawal. Soc. Neurosci. Abstr. 23: 1108.
38. 38. Gilman, A.G., L.S. Goodman, T.W. Rall & F. Murad 1985. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Macmillan. New York.
39. 39. Bing, G., S. Chen, Y. Zhang, D. Hillman & E.A. Stone. 1992. Noradrenergic-induced expression of c-fos in rat cortex: neuronal localisation. Neurosci. Lett. 140: 260-264.
40. 40. Stone, H.A., Y. Zhang, S. John, D. Filer & G. Bing. 1993. Effect of locus coeruleus lesion on c-fos expression in the cerebral cortex caused by yohimbine injection or stress. Brain Res. 603: 181-185.
41. 41. Rainbow, T.C., B. Parsons & B.B. Wolfe. 1984. Quantitative autoradiography of β1- and β2-adrenergic receptors in rat brain. Proc. Natl. Acad. Sci. USA 81: 1585-1589.
42. 42. Funada, M., T. Suzuki, Y. Sugano, M. Tsubai, M. Misawa, H. Ueda & Y. Misu. 1994. Role of β-adrenoreceptors in the expression of morphine withdrawal signs. Life Sci. 54: 113-118.
43. 43. Stinus, L., M. Le Moal & G.F. Koob. 1990. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767-73.
44. 44. Swanson, L.W. 1992. Brain Maps: Structure of the Rat Brain. Elsevier Sciences Publ. Amsterdam.